Thirty consecutive patients with stage IIIB-IV non small cell lung cancer were treated with a combination of cisplatin 80 mg/m2 on day 1 plus vinorelbine 25-30 mg/m2 on days 1, 8. This cycle was repeated every 3 weeks. The overall response rate was 46%, with 1 patient showing a complete response and 13 patients (43%) a partial response with a mean duration of 8.4+ months. Six patients had a stabilization and 10 progressed. The main toxicities were represented by myelosuppression and nausea/vomiting. Grade 3 leukopenia was seen in 33% of cases, grade 2 thrombocytopenia in 12%, and phlebitis in the injection vein in 16%. Mild constipation was also recorded. The combination of cisplatin plus vinorelbine is quite effective in advanced non small cell carcinoma of the lung, and may be safely given on an outpatient basis

Gebbia, V., Caruso, M., Valenza, R., Testa, A., Cannata, G., Verderame, F., et al. (1994). Vinorelbine plus cisplatinum for the treatment of Stage IIIB and IV Non Small Cell Lung Carcinoma. ANTICANCER RESEARCH, 14(3), 1247-1249.

Vinorelbine plus cisplatinum for the treatment of Stage IIIB and IV Non Small Cell Lung Carcinoma.

GEBBIA, Vittorio;CIPOLLA, Calogero;LATTERI, Mario;
1994-01-01

Abstract

Thirty consecutive patients with stage IIIB-IV non small cell lung cancer were treated with a combination of cisplatin 80 mg/m2 on day 1 plus vinorelbine 25-30 mg/m2 on days 1, 8. This cycle was repeated every 3 weeks. The overall response rate was 46%, with 1 patient showing a complete response and 13 patients (43%) a partial response with a mean duration of 8.4+ months. Six patients had a stabilization and 10 progressed. The main toxicities were represented by myelosuppression and nausea/vomiting. Grade 3 leukopenia was seen in 33% of cases, grade 2 thrombocytopenia in 12%, and phlebitis in the injection vein in 16%. Mild constipation was also recorded. The combination of cisplatin plus vinorelbine is quite effective in advanced non small cell carcinoma of the lung, and may be safely given on an outpatient basis
1994
Gebbia, V., Caruso, M., Valenza, R., Testa, A., Cannata, G., Verderame, F., et al. (1994). Vinorelbine plus cisplatinum for the treatment of Stage IIIB and IV Non Small Cell Lung Carcinoma. ANTICANCER RESEARCH, 14(3), 1247-1249.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10447/233837
Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus 34
  • ???jsp.display-item.citation.isi??? 30
social impact